ConductScience.org, home

Paper32061313

COVID-19: what is next for public health?

Heymann DL and 2 others. Lancet, 2020. Cited by 535 papers, by iCite.

Cite this record

ConductScience Library. COVID-19: what is next for public health? Papers, record 32061313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32061313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
COVID-19: what is next for public health?
PubMed
Journal
Lancet
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
535
iCite
Relative citation ratio, by iCite
31.7
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heymann DLDavid L
2Shindo NNahoko
3WHO Scientific and Technical Advisory Group for Infectious HazardsGroup

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronavirus InfectionsMajor topic
Pneumonia, ViralMajor topic
Public HealthMajor topic
Betacoronavirus
COVID-19
China
Disease Outbreaks
Humans
SARS-CoV-2
World Health Organization

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04358783Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 PneumoniaBackgroundClinicalTrials.gov
NCT06282354Telemedicine for Postoperative Follow-up After Oncological SurgeriesBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32419704[Prone positioning in management of COVID-19 hospitalized patients].https://conductscience.org/library/papers/32419704

Source PubMed

Download CSV of comments and corrections

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112933765The SARS epidemic in Hong Kong.J Epidemiol Community Health2003https://conductscience.org/library/papers/12933765PubMed
214681510The severe acute respiratory syndrome.N Engl J Med2003https://conductscience.org/library/papers/14681510PubMed
331986261A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.Lancet2020https://conductscience.org/library/papers/31986261PubMed
432007145Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet2020https://conductscience.org/library/papers/32007145PubMed

Download CSV of references

Cited by430

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 535 citations.

PMIDTitleJournalYearIn PapersSource
42646720The Epidemiological and Economic Burden of Vaccine-Preventable Respiratory Diseases Among Adults Aged 65 Years and Older in the Nordic Countries.Vaccines (Basel)2026https://conductscience.org/library/papers/42646720PubMed
42327853Long-term musculoskeletal impacts on the functionality of Brazilian patients after SARS-CoV-2: assessment through telehealth.Front Rehabil Sci2026https://conductscience.org/library/papers/42327853PubMed
41623341Impact of COVID-19 on Primary Healthcare Research: Trends and Suggestions for Better Services Approaches Via Blockchain Based Applications.Blockchain Healthc Today2025https://conductscience.org/library/papers/41623341PubMed
41608370Effectiveness of COVID-19 Vaccination in Reducing Severity Among SARS-CoV-2 Infected Patients: A Prospective Study From Iraq.Health Sci Rep2026https://conductscience.org/library/papers/41608370PubMed
41561712Suicides in India: A Forecasting for Immediate Investment to Save Lives.Indian J Community Med2025https://conductscience.org/library/papers/41561712PubMed
41046558
Delivering a family-based child mental health promotion program among two resettled refugee communities during the COVID-19 pandemic: Lessons learned in a hybrid type II implementation-effectiveness randomized controlled trial.
Am J Community Psychol2026https://conductscience.org/library/papers/41046558PubMed
40926885Long COVID-19 alters muscle architecture and muscle-tendon force transmission: a one-year longitudinal study.Front Physiol2025https://conductscience.org/library/papers/40926885PubMed
40713725Robust COVID-19 Mortality Risk Assessment: Validation of a Two-Step Algorithm From the National COVID Cohort Collaborative.J Infect Dis2026https://conductscience.org/library/papers/40713725PubMed
40689082The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome.Cell Insight2025https://conductscience.org/library/papers/40689082PubMed
40684227Google search interests and new cases of COVID-19 in Bangladesh: a vector autoregression analysis for disease surveillance.BMC Res Notes2025https://conductscience.org/library/papers/40684227PubMed
40469133The efficacy and safety of corticosteroids in treating severe COVID-19 patients: A meta-analysis with trial sequential analysis.Pak J Med Sci2025https://conductscience.org/library/papers/40469133PubMed
40149113Antibiotic Usage and Healthcare-Associated Clostridioides difficile in Patients with and Without COVID-19: A Tertiary Hospital Experience.Antibiotics (Basel)2025https://conductscience.org/library/papers/40149113PubMed
40144910Seroprevalence of antibodies against SARS-CoV-2 among workers in a national research institute and hospital in Central Japan.GHM Open2021https://conductscience.org/library/papers/40144910PubMed
39920706Using a co-design approach to develop a Preventative Online Mental Health Program for Youth (POMHPY): a quality improvement project.BMC Health Serv Res2025https://conductscience.org/library/papers/39920706PubMed
39876689The impact of the COVID-19 pandemic on time to treatment in head and neck cancer management: a systematic review.Acta Oncol2025https://conductscience.org/library/papers/39876689PubMed
39627231A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission.Nat Commun2024https://conductscience.org/library/papers/39627231PubMed
39624608Experiences of Nurses Diagnosed with COVID-19: A Qualitative Study.J Caring Sci2024https://conductscience.org/library/papers/39624608PubMed
39268423Physical, psychological, and social experiences of women recovered from COVID-19 in Iran: A qualitative study.J Educ Health Promot2024https://conductscience.org/library/papers/39268423PubMed
39135523Clinical effects of non-pharmaceutical interventions for COVID-19 on other nationally notifiable infectious diseases in South Korea.Korean J Intern Med2024https://conductscience.org/library/papers/39135523PubMed
39131571COVID-19 prevention and control effect of non-pharmaceutical interventions-fuzzy-sets qualitative comparative analysis based on 69 countries in the world.Front Public Health2024https://conductscience.org/library/papers/39131571PubMed

See all 430 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32061313

GET https://conductscience.org/api/papers/v1/32061313/cited_by?page=2